RUNX3 and neoplasm: The bone invasion and resultant osteolysis as well as the tumor volume were noticeably reduced in mice inoculated with Ca9.22 OSCC cells in which RUNX3 was knocked down, as supported by histological examination, bone morphometric μCT analyses, and the detection of bone turnover markers in the sera.